Weekly Docetaxel and Cisplatin with Concomitant Radiotherapy in Addition to Consolidation Chemotherapy
in Locally Advanced Non-Small Cell Lung Cancer

Research Abstract
NULL
Research Authors
Hanan G. Mostafa and Mohamed-Alaaeldeen H. Mohamed
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal
Cancer Biology 2016;6(1)
Research Member
Mohamed Alaa-Eldeen Hassan
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2016

NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER.

Research Abstract
NULL
Research Authors
Samia Abd ELkareem Ali, Hanan Gamal eldeen Mostafa, Mohamed Alaa Eldeen Hassan, Noha Adly Abo-Ela Mohamed
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal

Kasr El-Aini J. Clin. Oncol. Nucl. Med.
Jan.-April. 2015
Research Member
Noha Adly Abo-Elela Mohamed
Research Pages
NULL
Research Publisher
NULL
Research Rank
2
Research Vol
NULL
Research Website
NULL
Research Year
2015

NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER.

Research Abstract
NULL
Research Authors
Samia Abd ELkareem Ali, Hanan Gamal eldeen Mostafa, Mohamed Alaa Eldeen Hassan, Noha Adly Abo-Ela Mohamed
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal

Kasr El-Aini J. Clin. Oncol. Nucl. Med.
Jan.-April. 2015
Research Member
Prof.Hanan Gamal El-Din Moustafa Morsy
Research Pages
NULL
Research Publisher
NULL
Research Rank
2
Research Vol
NULL
Research Website
NULL
Research Year
2015

NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER.

Research Abstract
NULL
Research Authors
Samia Abd ELkareem Ali, Hanan Gamal eldeen Mostafa, Mohamed Alaa Eldeen Hassan, Noha Adly Abo-Ela Mohamed
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal

Kasr El-Aini J. Clin. Oncol. Nucl. Med.
Jan.-April. 2015
Research Member
Mohamed Alaa-Eldeen Hassan
Research Pages
NULL
Research Publisher
NULL
Research Rank
2
Research Vol
NULL
Research Website
NULL
Research Year
2015

NAVELBLINE AND CAPECITABINE (NAVCAP) FOLLOWED EITHER BY NAVCAP OR BY WEEKLY DOCETAXEL IN THE FIRST-LINE TREATMENT OF HER-2/NEU NEGATIVE METASTATIC BREAST CANCER.

Research Abstract
NULL
Research Authors
Samia Abd ELkareem Ali, Hanan Gamal eldeen Mostafa, Mohamed Alaa Eldeen Hassan, Noha Adly Abo-Ela Mohamed
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal

Kasr El-Aini J. Clin. Oncol. Nucl. Med.
Jan.-April. 2015
Research Member
Samir Shehata Mohamed Eid
Research Pages
NULL
Research Publisher
NULL
Research Rank
2
Research Vol
NULL
Research Website
NULL
Research Year
2015

CONCURRENT RADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK CANCER: ANALYSIS OF TREATMENT RESULTS AND PROGNOSTIC FACTORS

Research Abstract
NULL
Research Authors
Hanan Gamal–Eldeen Mostafa and Mohamed Alaa-Eldeen Hassan Mohamed
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal
Kasr El-Aini J. Clin. Oncol. Nucl. Med.
Vol.11, No.3-4, Jul. - Oct. 2015
Research Member
Prof.Hanan Gamal El-Din Moustafa Morsy
Research Pages
NULL
Research Publisher
NULL
Research Rank
2
Research Vol
NULL
Research Website
NULL
Research Year
2015

CONCURRENT RADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK CANCER: ANALYSIS OF TREATMENT RESULTS AND PROGNOSTIC FACTORS

Research Abstract
NULL
Research Authors
Hanan Gamal–Eldeen Mostafa and Mohamed Alaa-Eldeen Hassan Mohamed
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal
Kasr El-Aini J. Clin. Oncol. Nucl. Med.
Vol.11, No.3-4, Jul. - Oct. 2015
Research Member
Mohamed Alaa-Eldeen Hassan
Research Pages
NULL
Research Publisher
NULL
Research Rank
2
Research Vol
NULL
Research Website
NULL
Research Year
2015

Which is More Effective; Docetaxel, Doxorubicin
and Cyclophosphamide Or 5-Fluorouracil,
Doxorubicin and Cyclophosphamide in Adjuvant
Treatment of Early Stage Node Positive Breast
Cancer?

Research Abstract
NULL
Research Authors
Rehab F Mohamed1
, Abeer F Amin2
, Mohamed Alaa Elden Hassan Mohamed3
, Rania A Abdelhamid4
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal
International Journal of Science and Research (IJSR)
Research Member
Rehab Farouk Mohamed Qutb
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2015

Which is More Effective; Docetaxel, Doxorubicin
and Cyclophosphamide Or 5-Fluorouracil,
Doxorubicin and Cyclophosphamide in Adjuvant
Treatment of Early Stage Node Positive Breast
Cancer?

Research Abstract
NULL
Research Authors
Rehab F Mohamed1
, Abeer F Amin2
, Mohamed Alaa Elden Hassan Mohamed3
, Rania A Abdelhamid4
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal
International Journal of Science and Research (IJSR)
Research Member
Rania Ahmed Abdelhamid Mohammed Mahran
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2015

Which is More Effective; Docetaxel, Doxorubicin
and Cyclophosphamide Or 5-Fluorouracil,
Doxorubicin and Cyclophosphamide in Adjuvant
Treatment of Early Stage Node Positive Breast
Cancer?

Research Abstract
NULL
Research Authors
Rehab F Mohamed1
, Abeer F Amin2
, Mohamed Alaa Elden Hassan Mohamed3
, Rania A Abdelhamid4
Research Department
Department of Rheumatology ,Rehabilitation & physical medicine
Research Journal
International Journal of Science and Research (IJSR)
Research Member
Abeer Fayek Amin Mousa
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2015
Subscribe to